Karolina Rittner, et al.
AACR 2018, April 2018 – Abstract available on the AACR 2018 website
Download the poster here
Poster Presentation
Pseudocowpox: A next generation viral vector for cancer immunotherapy
By alcyon|2019-07-01T16:53:45+02:00April 18th, 2018|Publication|Comments Off on Pseudocowpox: A next generation viral vector for cancer immunotherapy
About the Author: alcyon
Related Posts
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity